Isavuconazole as an adjunctive antifungal in the multimodal management of pulmonary aspergilloma and chronic cavitary pulmonary aspergillosis: a single-centre case series.

Deviaene M, Dumoulin E, Somayaji R, Mody CH, Thornton CS

Open source

DOI
10.1016/j.rmcr.2026.102486
Published
2026
Container
Respiratory medicine case reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.rmcr.2026.102486,
  title = {Isavuconazole as an adjunctive antifungal in the multimodal management of pulmonary aspergilloma and chronic cavitary pulmonary aspergillosis: a single-centre case series.},
  author = {Deviaene M and Dumoulin E and Somayaji R and Mody CH and Thornton CS},
  year = {2026},
  journal = {Respiratory medicine case reports},
  doi = {10.1016/j.rmcr.2026.102486},
  url = {https://doi.org/10.1016/j.rmcr.2026.102486}
}

RIS

TY  - JOUR
TI  - Isavuconazole as an adjunctive antifungal in the multimodal management of pulmonary aspergilloma and chronic cavitary pulmonary aspergillosis: a single-centre case series.
AU  - Deviaene M
AU  - Dumoulin E
AU  - Somayaji R
AU  - Mody CH
AU  - Thornton CS
PY  - 2026
JO  - Respiratory medicine case reports
DO  - 10.1016/j.rmcr.2026.102486
UR  - https://doi.org/10.1016/j.rmcr.2026.102486
ER  - 

APA

M, D., E, D., R, S., CH, M., & CS, T. (2026). Isavuconazole as an adjunctive antifungal in the multimodal management of pulmonary aspergilloma and chronic cavitary pulmonary aspergillosis: a single-centre case series.. Respiratory medicine case reports. https://doi.org/10.1016/j.rmcr.2026.102486

Source records